Cyclin D1 (CCND1) expression is involved in estrogen receptor beta (ERβ) in human prostate cancer

Prostate

Volumn 73, Issue 6, 2013, Pages 590-595

  Nakamura, Yasuhiro ^a   Felizola, Saulo J A ^a   Kurotaki, Yumi ^a   Fujishima, Fumiyoshi ^a   McNamara, Keely M ^a   Suzuki, Takashi ^a   Arai, Yoichi ^a   Sasano, Hironobu ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

cyclin D1; ER ; prostate cancer

Indexed keywords

CYCLIN D1; ESTRADIOL; ESTROGEN RECEPTOR BETA; MESSENGER RNA; PROTEIN C FOS;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER PATIENT; CARCINOMA CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION;

AGED; CARCINOMA; CELL LINE, TUMOR; CELL NUCLEUS; CYCLIN D1; ESTROGEN RECEPTOR BETA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84875803322     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22599     Document Type: Article

References (34)

1. Hunter T, Pines J,. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 1994; 79: 573-582.
2. Sherr CJ,. Mammalian G1 cyclins. Cell 1994; 79: 551-555.
3. Weinstein IB, Zhou P,. Cell cycle control gene defects and human cancer. In:, Bertino JR, editor. Encyclopedia of Cancer, Vol 1. New York: Academic Press; 1996. pp. 256-267.
4. Han EK, Lim JT, Arber N, Rubin MA, Xing WQ, Weinstein IB,. Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors. Prostate 1998; 35: 95-101.
5. Perry JE, Tindall DJ,. Androgens regulate the expression of proliferating cell nuclear antigen posttranscriptionally in the human prostate cancer cell line, LNCaP. Cancer Res 1996; 56: 1539-1544.
6. McPherson SJ, Hussain S, Balanathan P, Hedwards SL, Niranjan B, Grant M, Chandrasiri UP, Toivanen R, Wang Y, Taylor RA, Risbridger GP,. Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated. Proc Natl Acad Sci U S A 2010; 107: 3123-3128.
7. Hurtado A, Pinõs T, Barbosa-Desongles A, Lõpez-Avilés S, Barquinero J, Petriz J, Santamaria-Martínez A, Morote J, de Torres I, Bellmunt J, Reventõs J, Munell F,. Estrogen receptor beta displays cell cycle-dependent expression and regulates the G1 phase through a non-genomic mechanism in prostate carcinoma cells. Cell Oncol 2008; 30: 349-365.
8. Nakamura Y, Suzuki T, Fukuda T, Ito A, Endo M, Moriya T, Arai Y, Sasano H,. Steroid sulfatase and estrogen sulfotransferase in human prostate cancer. Prostate 2006; 66: 1005-1012.
9. Nakamura Y, Suzuki T, Arai Y, Sasano H,. Nuclear receptor DAX1 in human prostate cancer: A novel independent biological modulator. Endocr J 2009; 56: 39-44.
10. Nakamura Y, Suzuki T, Sugawara A, Arai Y, Sasano H,. Peroxisome proliferator-activated receptor gamma in human prostate carcinoma. Pathol Int 2009; 59: 288-293.
11. Nakamura Y, Suzuki T, Nakabayashi M, Endoh M, Sakamoto K, Mikami Y, Moriya T, Ito A, Takahashi S, Yamada S, Arai Y, Sasano H,. In situ androgen producing enzymes in human prostate cancer. Endocr Relat Cancer 2005; 12: 101-107.
12. Linja MJ, Savinainen KJ, Tammela TL, Isola JJ, Visakorpi T,. Expression of ERalpha and ERbeta in prostate cancer. Prostate. 2003; 55: 180-186.
13. Hsieh TC, Yang CJ, Lin CY, Lee YS, Wu JM,. Control of stability of cyclin D1 by quinone reductase 2 in CWR22Rv1 prostate cancer cells. Carcinogenesis 2012; 33: 670-677.
14. Chen Y, Martinez LA, LaCava M, Coghlan L, Conti CJ,. Increased cell growth and tumorigenicity in human prostate LNCaP cells by overexpression to cyclin D1. Oncogene 1998; 16: 1913-1920.
15. Gumbiner LM, Gumerlock PH, Mack PC, Chi SG, deVere White RW, Mohler JL, Pretlow TG, Tricoli JV,. Overexpression of cyclin D1 is rare in human prostate carcinoma. Prostate 1999; 38: 40-45.
16. Vlachostergios PJ, Karasavvidou F, Patrikidou A, Voutsadakis IA, Kakkas G, Moutzouris G, Zintzaras E, Daliani DD, Melekos MD, Papandreou CN,. p53 and cyclooxygenase-2 expression are directly associated with cyclin D1 expression in radical prostatectomy specimens of patients with Hormone-Naïve prostate cancer. Pathol Oncol Res 2012; 18: 245-252.
17. Feng FY, Qian Y, Stenmark MH, Halverson S, Blas K, Vance S, Sandler HM, Hamstra DA,. Perineural invasion predicts increased recurrence, metastasis, and death from prostate cancer following treatment with dose-escalated radiation therapy. Int J Radiat Oncol Biol Phys 2011; 81: e361-e367.
18. Katz B, Srougi M, Dall'oglio M, Nesrallah AJ, Sant'anna AC, Pontes J Jr, Antunes AA, Reis ST, Viana N, Sañudo A, Camara-Lopes LH, Leite KR,. Perineural invasion detection in prostate biopsy is related to recurrence-free survival in patients submitted to radical prostatectomy. Urol Oncol http://dx.doi.org/10.1016/j.urolonc.2010.11.008.
19. Fromont G, Godet J, Pires C, Yacoub M, Dore B, Irani J,. Biological significance of perineural invasion (PNI) in prostate cancer. Prostate 2012; 72: 542-548.
20. Tian J, Berton TR, Shirley SH, Lambertz I, Gimenez-Conti IB, DiGiovanni J, Korach KS, Conti CJ, Fuchs-Young R,. Developmental stage determines estrogen receptor alpha expression and non-genomic mechanisms that control IGF-1 signaling and mammary proliferation in mice. J Clin Invest 2012; 122 (1): 192-204.
21. Ming J, Jiang G, Zhang Q, Qiu X, Wang E,. Interleukin-7 up-regulates cyclin D1 via activator protein-1 to promote proliferation of cell in lung cancer. Cancer Immunol Immunother 2012; 61: 79-88.
22. Peng Y, Li H, Wu M, Wang X, Fan S, Liu F, Xiang B, Guo Q, Tang X, Shen S,. NGX6 inhibits AP-1 and Ets-1 expression and down-regulates cyclin D1 in human colorectal cancer. Acta Biochim Biophys Sin (Shanghai) 2009; 41: 504-514.
23. Sharma P, Kumar S, Kundu GC,. Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells. Mol Cancer 2010; 9: 178.
24. O'Hara J, Vareslija D, McBryan J, Bane F, Tibbitts P, Byrne C, Conroy RM, Hao Y, Gaora PÓ, Hill AD, McIlroy M, Young LS,. AIB1: ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells. Clin Cancer Res 2012; 18: 3305-3315.
25. Luo GQ, Li JH, Cao L, Zhou YH, Wen JF,. Activator protein-1 involvement in proliferation inhibition by gene silencing of Twist in gastric cancer cells. Pathology 2011; 43: 697-701.
26. Ouyang X, Jessen WJ, Al-Ahmadie H, Serio AM, Lin Y, Shih WJ, Reuter VE, Scardino PT, Shen MM, Aronow BJ, Vickers AJ, Gerald WL, Abate-Shen C,. Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer. Cancer Res 2008; 68: 2132-2144.
27. Hiramatsu M, Maehara I, Ozaki M, Harada N, Orikasa S, Sasano H,. Aromatase in hyperplasia and carcinoma of the human prostate. Prostate 1997; 31 (2): 118-124.
28. Kawashima H, Nakatani T,. Involvement of estrogen receptors in prostatic diseases. Int J Urol 2012; 19: 512-522.
29. Hurtado A, Pinos T, Barbosa-Desongles A, Lõpez-Avilés S, Barquinero J, Petriz J, Santamaria-Martínez A, Morote J, de Torres I, Bellmunt J, Reventõs J, Munell F,. Estrogen receptor beta displays cell cycle-dependent expression and regulates the G1 phase through a non-genomic mechanism in prostate carcinoma cells. Cell Oncol 2008; 30: 349-365.
30. Cheng J, Lee EJ, Madison LD, Lazennec G,. Expression of estrogen receptor β in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis. FEBS Lett 2004; 566: 169-172.
31. Rossi V, Bellastella G, De Losa C, Abbondanza C, Visconti D, Maione L, Chieffi P, Della Ragione F, Prezioso D, De Bellis A, Bellastella A, Sinisi AA,. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β. J Cell Physiol 2011; 226: 1334-1339.
32. Leung Y-K, Gao Y, Lau K-M, Zhang X,., Ho S-M,. ICI 182 780-regulated gene expression in DU145 prostate cancer cells is mediated by estrogen receptor-β/NFκB crosstalk. Neoplasia 2006; 8: 242-249.
33. Matsumura K, Tanaka T, Kawashima H, Nakatani T,. Involvement of the estrogen receptor β in genistein-induced expression of p21 waf1/cip1 in PC-3 prostate cancer cells. Anticancer Res 2008; 28: 709-714.
34. Nakajima Y, Akaogi K, Suzuki T, Osakabe A, Yamaguchi C, Sunahara N, Ishida J, Kako K, Ogawa S, Fujimura T, Homma Y, Fukamizu A, Murayama A, Kimura K, Inoue S, Yanagisawa J,. Estrogen regulates tumor growth through a non-classical pathway that includes the transcription factors ERβ and KLF5. Sci Signal 2011; 4: ra22.